Form 4: Evolv Technologies Director Kevin Charlton Granted 27,050 Restricted Stock Units

Sentiment:

Insider Transaction Report


Evolv Technologies Holdings, Inc. Director Kevin M. Charlton was granted 27,050 Restricted Stock Units (RSUs) on June 20, 2025, aligning his interests with shareholders.

Summary

  • Kevin M. Charlton, a Director of Evolv Technologies Holdings, Inc. (EVLV), was granted 27,050 Restricted Stock Units (RSUs).
  • The transaction date for this grant was June 20, 2025.
  • Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock.
  • The RSUs have no expiration date.
  • The RSUs are scheduled to vest in full at the earlier of June 20, 2026, or the day immediately preceding the Issuer's next annual meeting date.
  • Following this transaction, Mr. Charlton beneficially owns 27,050 Restricted Stock Units directly.

Sentiment

Score: 6

Explanation: The grant of Restricted Stock Units to a director is a positive signal of alignment between management and shareholder interests, though it is a routine compensation event and not indicative of significant operational news.

Positives

  • The grant of 27,050 Restricted Stock Units to Director Kevin M. Charlton aligns his interests with those of shareholders, as the value of the RSUs is tied to the future performance of Evolv Technologies' Class A common stock.
  • The vesting schedule, tied to a future date or the next annual meeting, incentivizes long-term commitment and performance from the director.

Future Outlook

The 27,050 Restricted Stock Units granted to Director Kevin M. Charlton are scheduled to vest in full at the earlier of June 20, 2026, or the day immediately preceding the Issuer's next annual meeting date, indicating a future equity award realization event.

Industry Context

This Form 4 filing is a routine disclosure of an equity compensation grant to a director, common practice across publicly traded companies to align management and board interests with shareholders. It does not provide broader industry trends or competitive analysis.

Comparison to Industry Standards

  • The grant of Restricted Stock Units (RSUs) as a form of equity compensation to directors is a standard practice in corporate governance across various industries, including technology and security solutions.
  • While the specific number of units (27,050) is particular to Evolv Technologies Holdings, Inc. and Director Kevin M. Charlton, the mechanism of using RSUs with a vesting schedule is consistent with compensation strategies employed by comparable companies to incentivize long-term performance and retention.
  • No specific comparable companies or projects are mentioned in this filing.

Related Party Transactions

  • The grant of Restricted Stock Units to a director is an insider transaction, which is a form of related party dealing, but it is a standard compensation practice and not indicative of unusual related party transactions requiring specific disclosure beyond the Form 4 itself.

Stakeholder Impact

  • Shareholders: The grant of RSUs to a director helps align the director's financial interests with those of the shareholders, potentially encouraging decisions that enhance long-term shareholder value.
  • Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

  • The Restricted Stock Units granted to Kevin M. Charlton are expected to vest in full at the earlier of June 20, 2026, or the day immediately preceding the Issuer's next annual meeting date.

Key Dates

DateDescription
06/20/2025Date of grant for 27,050 Restricted Stock Units to Kevin M. Charlton.
06/24/2025Date the Form 4 was signed by Rachel Roy, Attorney-in-fact for Kevin Charlton.
06/20/2026Earliest potential full vesting date for the Restricted Stock Units.

Keywords

Evolv Technologies Holdings Inc., EVLV, SEC Form 4, Restricted Stock Units, RSU grant, insider transaction, director compensation, equity compensation, Kevin Charlton

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.